Literature DB >> 16141008

Association of genes of lipid metabolism with measures of subclinical cardiovascular disease in the Diabetes Heart Study.

K P Burdon, C D Langefeld, S R Beck, L E Wagenknecht, J J Carr, B I Freedman, D Herrington, D W Bowden.   

Abstract

BACKGROUND: Dyslipidaemia is a well known risk factor for cardiovascular disease (CVD). Lipid metabolism is affected by a range of genes and proteins. This study investigated whether some of these genes are associated with measures of subclinical CVD.
METHODS: Polymorphisms of paraoxonase 1 and 2, cholesteryl ester transfer protein, hepatic lipase, and lipoprotein lipase were tested for associations with measures of subclinical CVD including carotid intima-media thickness measured by B-mode ultrasound and carotid and coronary arterial calcification measured by computed tomography. Analysis was performed in 620 European American participants in the Diabetes Heart Study, 83% of whom had type 2 diabetes mellitus. Associations of genotypes with subclinical CVD were tested by computing a series of generalised estimating equations.
RESULTS: The Q192R variant of paraoxonase 1 and rs285 of lipoprotein lipase were associated with carotid artery calcium (p values = 0.002 and 0.005, respectively). Paraoxonase 2 S311C was associated with coronary artery calcium (p value = 0.037).
CONCLUSIONS: There is evidence for modest, but significant, association of multiple single nucleotide polymorphisms in lipid genes with measures of subclinical CVD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141008      PMCID: PMC1736137          DOI: 10.1136/jmg.2004.029850

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

Review 1.  The genetics of vascular complications in diabetes mellitus.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

2.  Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity.

Authors:  C Zhang; R Lopez-Ridaura; E B Rimm; T Li; D J Hunter; F B Hu
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

Review 3.  Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications.

Authors:  Donald W Bowden; Amanda J Cox; Barry I Freedman; Christina E Hugenschimdt; Lynne E Wagenknecht; David Herrington; Subhashish Agarwal; Thomas C Register; Joseph A Maldjian; Maggie C-Y Ng; Fang-Chi Hsu; Carl D Langefeld; Jeff D Williamson; J Jeffrey Carr
Journal:  Rev Diabet Stud       Date:  2010-11-10

4.  High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.

Authors:  Muhammad Hammadah; Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Malory Weber; Yuping Wu; Stanley L Hazen; Javed Butler; W H Wilson Tang
Journal:  Eur J Heart Fail       Date:  2017-02-07       Impact factor: 15.534

5.  Paraoxonase 1 polymorphisms and risk of myocardial infarction in women and men.

Authors:  Kenneth J Mukamal; Jennifer K Pai; Majken K Jensen; Eric B Rimm
Journal:  Circ J       Date:  2009-05-15       Impact factor: 2.993

Review 6.  Genetic variants of the Renin Angiotensin system: effects on atherosclerosis in experimental models and humans.

Authors:  Alan Daugherty; Aruna Poduri; Xiaofeng Chen; Hong Lu; Lisa A Cassis
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

7.  Association between hepatic lipase -514 C/T promoter polymorphism and myocardial infarction is modified by history of hypercholesterolemia and waist circumference.

Authors:  A Baylin; E Ruiz-Narvaez; M K Jensen; E Rimm; H Campos
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-08-19       Impact factor: 4.222

8.  Association between the Hepatic Lipase Promoter Region Polymorphism (-514 C/T) and the Presence and Severity of Premature Coronary Artery Disease.

Authors:  Hamidreza Goodarzynejad; Mohammadali Boroumand; Mehrdad Behmanesh; Shayan Ziaee; Arash Jalali; Leyla Pourgholi
Journal:  J Tehran Heart Cent       Date:  2017-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.